tiprankstipranks
Trending News
More News >

Cocrystal Pharma price target lowered to $6 from $7 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Cocrystal Pharma (COCP) to $6 from $7 and keeps a Buy rating on the shares. The firm says CDI-988 demonstrated “further promise” via activity against emergent norovirus variants. It cites anticipated equity dilution for the target cut.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1